Preferred Pharmaceuticals, Inc. recalls Lidocaine Ointment USP
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Failed Content Uniformity Specifications
- Products
-
- Lidocaine Ointment USP
- Where it was sold
-
USA Nationwide
Nationwide
- Units affected
- N/A
- About this recall
- Lidocaine Ointment USP, 5% (Generic for Xylocaine), packaged in a 50 g jar, Rx only, Mfg: Taro Pharmaceuticals U.S.A., Inc., Prod# (NDC): 68788-7865-05